undefined

 


The Percutaneous practices are used in surgical procedures on the soft tissues and bones of the foot. Neuromodulation is the process to regulate perse populations of neurons by use of chemicals. The percutaneous tibial neuromodulation is a new advanced technique used in patients with overactive bladder (OAB) and improves the quality of life. The device uses electrical pulses to stimulate the tibial nerve, running posterior to the malleolus and elongated to the sacral nerve plexus. The whole process is called percutaneous tibial neuromodulation or percutaneous tibial neurostimulation.  Increase in the prevalence of urological diseases and number of patients undergoing urological treatment is increasing significantly. Technological advancements in the medical field have resulted in increasing the number of procedures/medications for urological diseases, leading to rising in demand for tibial neuromodulation devices.

 

The neuromodulation devices are clinically accessed and provide safe, effective and minimally invasive treatment options. The percutaneous tibial neuromodulation devices are cost-effective and the procedure can be performed in office-based treatment centers. The device is helpful both to the professional and patient as it is portable and inexpensive therapy. The device is tested and is effective in both men and women. The common side effects are the pain, skin inflammation near the stimulation site. The procedure involves to place the electrode needle to the lower side of the leg slightly to the malleolus. The ground pad is fitted to the base of the device and followed to the heel bone on the leg. The patient is treated once per week and completes at least twelve therapy sessions.

Advancement in the tibial neuromodulator devices due to research and development and companies focus on organic growth will support the physicians with the wide range of devices used on an outpatient basis and offers new patients with new treatment procedure where conservative treatments do not work. This advancement will boost the percutaneous tibial neuromodulation devices in the near future

Percutaneous Tibial Neuromodulation Devices Market: Drivers and Restrains

Rising incidence of urological disease, increase in demand for minimally invasive procedure, usage in outpatient basis are the factors favouring market growth over the forecast period. The use of neuromodulator devices is gaining popularity and enabling surgeons the power, precision, and control needed for soft or hard tissue, bone modulation. The factors limiting the market growth is high treatment cost, less awareness about the devices and other treatment options prevailing in the market. Growth opportunities such as increasing market share through mergers and acquisitions and investing in emerging economics, technological advancement in percutaneous tibial neuromodulation devices is boosting the growth of the target market

 

Percutaneous Tibial Neuromodulation Devices Market: Key Players

Some of the key players in global percutaneous tibial neuromodulation devices market are Cogentix Medical, Palex Medical SA, Medtronic plc. Rainbow Medical Group and others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report covers exhaustive analysis on:

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

Percutaneous Tibial Neuromodulation Devices Market: Segmentation

The global percutaneous tibial neuromodulation devicesmarket has been classified on the basis of application, end user and geography.

Based on the Application, the global percutaneous tibial neuromodulation devices market is pided into following:

  • Faecal Incontinence
  • Overactive Bladder

 

Based on the End User, the global percutaneous tibial neuromodulation devices market is pided into following:

  • Hospital
  • Ambulatory Surgical centers
  • Clinics
  • Specialty Care Unit
  • Others

 

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

 

Contact:

Future Market Insights,

1602-6 Jumeirah Bay X2 Tower,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

For Sales Enquiries: [email protected]

For Media Enquiries: [email protected]

Website: https://www.futuremarketinsights.com/